Literature DB >> 35502083

Fulminant fungal endogenous endophthalmitis following SARS-CoV-2 infection: A case report.

Mukesh Jain1, Anand Singh Brar1, Suryasnata Rath2, Anup Kelgaokar1, Himansu Sekhar Behera3.   

Abstract

Systemic corticosteroids and immunocompromised state following SARS-CoV-2 infection can predispose individuals to endogenous endophthalmitis. A 66-year-old gentleman presented with complaints of diminution of vision and redness one week post discharge after hospitalization for COVID-19 infection. Clinical examination suggested fulminant endogenous endophthalmitis which responded poorly even after aggressive treatment requiring evisceration. Culture and gene sequenced analysis confirmed Aspergillus fumigatus to be the causative organism. A high degree of suspicion is warranted in the presence of recent onset of floaters in COVID-19-infected individuals to facilitate early diagnosis and outcomes.

Entities:  

Keywords:  Aspergillus fusarium; COVID-19 infections; SARS-CoV-2; endogenous endophthalmitis; fungus

Mesh:

Year:  2022        PMID: 35502083      PMCID: PMC9333037          DOI: 10.4103/ijo.IJO_1951_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   2.969


  9 in total

1.  Endogenous endophthalmitis: microorganisms, disposition and prognosis.

Authors:  Thomas Ness; Klaus Pelz; Lutz Lothar Hansen
Journal:  Acta Ophthalmol Scand       Date:  2007-08-28

2.  A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients.

Authors:  Kunal K Shah; Devendra Venkatramani; Parthopratim Dutta Majumder
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

3.  Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban.

Authors:  Oana M Dumitrascu; Oksana Volod; Swaraj Bose; Yao Wang; Valérie Biousse; Patrick D Lyden
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-23       Impact factor: 2.136

4.  Mucor in a Viral Land: A Tale of Two Pathogens.

Authors:  Mrittika Sen; Sumeet Lahane; Tatyarao P Lahane; Ragini Parekh; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

5.  Ophthalmic manifestations in the COVID-19 clinical spectrum.

Authors:  K Kiran Kumar; U C Sampritha; Akshata A Prakash; Karishma Adappa; S Chandraprabha; T G Neeraja; N S Guru Prasad; Jessica Basumatary; Suresh Babu Gangasagara; B L Sujatha Rathod; Chakravarthy Raghunathan Jayanthi
Journal:  Indian J Ophthalmol       Date:  2021-03       Impact factor: 1.848

6.  Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection.

Authors:  Jonathan Virgo; Moin Mohamed
Journal:  Eye (Lond)       Date:  2020-07-03       Impact factor: 3.775

7.  Retinal vein occlusion in COVID-19: A novel entity.

Authors:  Jay Umed Sheth; Raja Narayanan; Jay Goyal; Vinod Goyal
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

8.  Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease.

Authors:  Daraius Shroff; Ritesh Narula; Neelam Atri; Arindam Chakravarti; Arpan Gandhi; Neelam Sapra; Gagan Bhatia; Shraddha R Pawar; Shishir Narain
Journal:  Indian J Ophthalmol       Date:  2021-07       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.